Device Core Lab

Cobas Pro Ise Analytical Unit

Payments companies reported to CMS as associated with Cobas Pro Ise Analytical Unit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$22Kassociated payments (2023-2025)
38clinicians with associated payments
1company reporting

By year

2023 $20K
2024 $813
2025 $600

Payments reported as associated with Cobas Pro Ise Analytical Unit, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Anatomic Pathology & Clinical Pathology $13K
Clinical Pathology/Laboratory Medicine $3,206
Pediatric Nephrology $2,938
Molecular Genetic Pathology (Pathology) $2,352
Clinical Pathology $136
Cardiovascular Disease $35.84

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Cobas Pro Ise Analytical Unit

These are the largest totals companies reported as associated with Cobas Pro Ise Analytical Unit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Myra Wilkerson Danville, PA Anatomic Pathology & Clinical Pathology $9,432.62
Michael Prystowsky Bronx, NY Clinical Pathology/Laboratory Medicine $3,021.19
Amy Fox Bronx, NY Pediatric Nephrology $2,938.42
Lucia Wolgast Bronx, NY Anatomic Pathology & Clinical Pathology $2,401.04
Doctor Goldstein Bronx, NY Molecular Genetic Pathology (Pathology) $2,352.08
Lisa Stempak Cleveland, OH Anatomic Pathology & Clinical Pathology $299.61
Leah Militello Rochester, NY Clinical Pathology $135.79
Sarah Sharghi Kalamazoo, MI Anatomic Pathology & Clinical Pathology $123.73
He Yang Valencia, CA Clinical Pathology/Laboratory Medicine $107.04
Amy Chadburn New York, NY Anatomic Pathology & Clinical Pathology $107.04

Prescribed Cobas Pro Ise Analytical Unit?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.